BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Girolamo, N.
Right arrow Articles by Wakefield, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Girolamo, N.
Right arrow Articles by Wakefield, D.
Br J Ophthalmol 1999;83:1077-1082 ( September )

Culture and characterisation of epithelial cells from human pterygia

Nick Di Girolamoa, Nicodemus Tedlaa, Rakesh K Kumara, Peter McCluskeya, Andrew Lloyda, Minas T Coroneob, Denis Wakefielda

a Inflammation Research Unit, School of Pathology, University of New South Wales, Australia, b Department of Ophthalmology, Prince of Wales Hospital, Sydney, 2052, Australia

Correspondence to: Dr Nick Di Girolamo, Inflammation Research Unit, School of Pathology, The University of New South Wales, Sydney, 2052, Australia.

Accepted for publication 18 May 1999

BACKGROUND/AIMS---Pterygia are a common disorder of the ocular surface. The disease represents a chronic fibrovascular and degenerative process thought to originate at the conjunctival-corneal junction, where altered limbal stem cells are proposed to be the cell of origin. Extensive epidemiological evidence exists to implicate ultraviolet B irradiation in the pathogenesis of pterygia. To date no animal or in vitro culture model has been developed to test such an hypothesis. The aim of this study was to establish and characterise a pure population of epithelial cells derived from pterygium tissue.
METHODS---Tissue specimens were obtained from patients undergoing pterygium excision. Explants were cultured in either serum free or serum supplemented medium. Primary and passaged cells were processed for light microscopy, analysed by flow cytometry, and characterised immunohistochemically using specific antibodies.
RESULTS---In serum free culture, cuboidal cells with typical morphology of epithelial cells migrated from the pterygium explants from 3 days onwards and eventually formed a cohesive monolayer. Passaged cells consisted of 98.4% cytokeratin positive cells and demonstrated immunoreactivity for multiple cytokeratins, including AE1, AE3, AE5, but were negative for AE8. These cells also expressed an epithelial specific antigen, together with vimentin and mucin, as did epithelial cells in sections of pterygia.
CONCLUSIONS---A relatively simple method of isolating pterygium epithelial cells has been established. Cultured pterygium epithelial cells are phenotypically and functionally similar to their in vivo counterparts with respect to keratin, vimentin, and mucin expression. In vitro assays using these cells may aid in elucidating the pathogenesis of pterygia.


© 1999 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
IOVSHome page
J. Ng, M. T. Coroneo, D. Wakefield, and N. Di Girolamo
Ultraviolet Radiation and the Role of Matrix Metalloproteinases in the Pathogenesis of Ocular Surface Squamous Neoplasia
Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5295 - 5306.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Chui, N. Di Girolamo, M. T. Coroneo, and D. Wakefield
The Role of Substance P in the Pathogenesis of Pterygia
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4482 - 4489.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N. Di Girolamo, J. Chui, D. Wakefield, and M. T Coroneo
Cultured human ocular surface epithelium on therapeutic contact lenses
Br. J. Ophthalmol., April 1, 2007; 91(4): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Di Girolamo, D. Wakefield, and M. T. Coroneo
UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. M. Nolan, N. Di Girolamo, M. T. Coroneo, and D. Wakefield
Proliferative Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor on Pterygium Epithelial Cells and Fibroblasts
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 110 - 113.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Di Girolamo, M. T. Coroneo, and D. Wakefield
UVB-Elicited Induction of MMP-1 Expression in Human Ocular Surface Epithelial Cells Is Mediated through the ERK1/2 MAPK-Dependent Pathway
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4705 - 4714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. M. Nolan, N. DiGirolamo, N. H. Sachdev, T. Hampartzoumian, M. T. Coroneo, and D. Wakefield
The Role of Ultraviolet Irradiation and Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Pathogenesis of Pterygium
Am. J. Pathol., February 1, 2003; 162(2): 567 - 574.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Di Girolamo, R. K. Kumar, M. T. Coroneo, and D. Wakefield
UVB-Mediated Induction of Interleukin-6 and -8 in Pterygia and Cultured Human Pterygium Epithelial Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3430 - 3437.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Di Girolamo, P. McCluskey, A. Lloyd, M. T. Coroneo, and D. Wakefield
Expression of MMPs and TIMPs in Human Pterygia and Cultured Pterygium Epithelial Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 671 - 679.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.